These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 24311645)

  • 41. Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.
    Yu CY; Liang GB; Du P; Liu YH
    Asian Pac J Cancer Prev; 2013; 14(8):4907-11. PubMed ID: 24083766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
    Verma BK; Kondaiah P
    J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.
    Cheng CY; Chou YE; Ko CP; Yang SF; Hsieh SC; Lin CL; Hsieh YH; Chen KC
    J Neurooncol; 2014 Nov; 120(2):273-81. PubMed ID: 25048531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
    Wang Q; Sun ZX; Allgayer H; Yang HS
    Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
    Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
    Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
    Xu X; Tang X; Guo W; Yang K; Ren T
    Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50.
    Wang R; Jiao Z; Li R; Yue H; Chen L
    Neuro Oncol; 2012 Sep; 14(9):1116-24. PubMed ID: 22810421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
    Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
    J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
    Zhang D; Guo S; Wang H; Hu Y
    Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
    Yu G; Wu F; Wang E
    Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.